Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Saniona

Saniona

16,28SEK
0,00% (0,00)
Päätöskurssi
Ylin-
Alin-
Vaihto-
16,28SEK
0,00% (0,00)
Päätöskurssi
Ylin-
Alin-
Vaihto-

Saniona

Saniona

16,28SEK
0,00% (0,00)
Päätöskurssi
Ylin-
Alin-
Vaihto-
16,28SEK
0,00% (0,00)
Päätöskurssi
Ylin-
Alin-
Vaihto-

Saniona

Saniona

16,28SEK
0,00% (0,00)
Päätöskurssi
Ylin-
Alin-
Vaihto-
16,28SEK
0,00% (0,00)
Päätöskurssi
Ylin-
Alin-
Vaihto-
Q2-osavuosiraportti

Vain PDF

83 päivää sitten
0,0823 SEK/osake
Viimeisin osinko

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
0
Myynti
Määrä
0

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----
Ylin
-
VWAP
16,28
Alin
-
Vaihto ()
-
VWAP
16,28
Ylin
-
Alin
-
Vaihto ()
-

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q3-osavuosiraportti
27.11.
Menneet tapahtumat
2025 Q2-osavuosiraportti28.8.
2025 Q1-osavuosiraportti28.5.
2024 Yhtiökokous28.5.
2024 Q4-osavuosiraportti27.2.
2024 Q3-osavuosiraportti28.11.2024
Datan lähde: Millistream, Quartr

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Must say that Saniona is showing strength 💪 in a market that is otherwise just taking a breather. Impressive - I am otherwise one of the few who is a bit "critical" of the current price level 👍
    22 t sitten · Muokattu
    ·
    22 t sitten · Muokattu
    ·
    I "chatted" and it added history, depth, and overview to my analysis. And I read lots of reports, analyses, and irrelevant posts in various discussion forums (where I also gladly contribute with empty irrelevant posts, so we can all have something to pass the time with)
  • 15.11.
    ·
    15.11.
    ·
    Ha, ha, super nice. Just discovered that you can mute a person's posts, so they disappear……..AWESOME. Can you guess who I muted?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Slowfox, maybe!
  • 14.11.
    ·
    14.11.
    ·
    Buy and sell on Nordnet is pure rubbish, if one sees it as 3.89 % up
  • 13.11. · Muokattu
    ·
    13.11. · Muokattu
    ·
    Yet another well-founded and fully explained price movement following Affärsvärlden's entirely well-founded warning that things have probably moved a bit fast, and the valuation looks a tad strained. We can hope Saniona becomes the exception :-) : "Affärsvärlden emphasizes that the main scenario for speculative companies is that over time it ends with a large loss for investors." After having realized 2/3 with a decent profit, I now hold 10,000 at AAC 5.84 in Nordnet accounts and 10,000 at AAC 11.15 in bank accounts. I'm calmly waiting for anything between 5 and 25 depending on the panic from a rejection, a sell-off, or FOMO upon approval of Tesofensine in Mexico. Regardless of whether it's 5 or 25, I'll probably buy a bit more when there's clarification and people (perhaps) start to relax a bit. I must repeat that the only ones "messing" with the price here are the small investors who panic or go on a buying spree. Well, it's certainly entertaining to read along.
    14.11.
    ·
    14.11.
    ·
    It's simply not a sustainable argument to say "it has risen a lot, so it should fall". And the risk/probability is precisely included in a thorough analysis such as the one Redeye has made, with a base of 19 SEK. One should not then again include the risk of something going wrong - then it's a double safety factor.. But I agree that it is fully understandable that the stock price reacts to such an article. When one considers the total number of owners of the stock, and how few may have familiarized themselves 100% with the company, then there must be many who rely on the analyses and press releases that are announced.
    14.11. · Muokattu
    ·
    14.11. · Muokattu
    ·
    I agree with that - and I certainly hope it's not the only thing you read from my post. And I would say I might have looked into the case a bit more than the average :-). In any case, I'm trying to add that it might have moved a bit faster than the fundamental changes the 2 agreements + their choice of own development can support. That's my assessment/perception - and one doesn't have to agree with it in any way. But I added to my position myself (as I have done many times in the last 11 years) at a price of 2,00 on 24/4'2024 - i.e., just under 18 months ago - a 7-8 doubling in that period, which I simply don't believe can be justified by what has happened in that period. I understand that the 2,00 was probably too pessimistic, but in the same way, I think a price of 15-16 (2 billion SEK in market value) is probably on the high side now. I didn't consider selling at 11-12, but when I saw that in a very short time I could reduce my exposure with a gain of 40% in + (at the same time as I think 15-16 is too high), I went for it. Now we'll see - when Tesofensine is clarified, I think all of us small investors will reposition ourselves, and then we'll see if I should go in with a bit more at 8 or 22.
  • 13.11.
    ·
    13.11.
    ·
    The headline is .Saniona: Potential in pipeline I guess some stop/loss orders were just triggered. There must be some who got some shares at a discount given the share price last week.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

Q2-osavuosiraportti

Vain PDF

83 päivää sitten
0,0823 SEK/osake
Viimeisin osinko

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Must say that Saniona is showing strength 💪 in a market that is otherwise just taking a breather. Impressive - I am otherwise one of the few who is a bit "critical" of the current price level 👍
    22 t sitten · Muokattu
    ·
    22 t sitten · Muokattu
    ·
    I "chatted" and it added history, depth, and overview to my analysis. And I read lots of reports, analyses, and irrelevant posts in various discussion forums (where I also gladly contribute with empty irrelevant posts, so we can all have something to pass the time with)
  • 15.11.
    ·
    15.11.
    ·
    Ha, ha, super nice. Just discovered that you can mute a person's posts, so they disappear……..AWESOME. Can you guess who I muted?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Slowfox, maybe!
  • 14.11.
    ·
    14.11.
    ·
    Buy and sell on Nordnet is pure rubbish, if one sees it as 3.89 % up
  • 13.11. · Muokattu
    ·
    13.11. · Muokattu
    ·
    Yet another well-founded and fully explained price movement following Affärsvärlden's entirely well-founded warning that things have probably moved a bit fast, and the valuation looks a tad strained. We can hope Saniona becomes the exception :-) : "Affärsvärlden emphasizes that the main scenario for speculative companies is that over time it ends with a large loss for investors." After having realized 2/3 with a decent profit, I now hold 10,000 at AAC 5.84 in Nordnet accounts and 10,000 at AAC 11.15 in bank accounts. I'm calmly waiting for anything between 5 and 25 depending on the panic from a rejection, a sell-off, or FOMO upon approval of Tesofensine in Mexico. Regardless of whether it's 5 or 25, I'll probably buy a bit more when there's clarification and people (perhaps) start to relax a bit. I must repeat that the only ones "messing" with the price here are the small investors who panic or go on a buying spree. Well, it's certainly entertaining to read along.
    14.11.
    ·
    14.11.
    ·
    It's simply not a sustainable argument to say "it has risen a lot, so it should fall". And the risk/probability is precisely included in a thorough analysis such as the one Redeye has made, with a base of 19 SEK. One should not then again include the risk of something going wrong - then it's a double safety factor.. But I agree that it is fully understandable that the stock price reacts to such an article. When one considers the total number of owners of the stock, and how few may have familiarized themselves 100% with the company, then there must be many who rely on the analyses and press releases that are announced.
    14.11. · Muokattu
    ·
    14.11. · Muokattu
    ·
    I agree with that - and I certainly hope it's not the only thing you read from my post. And I would say I might have looked into the case a bit more than the average :-). In any case, I'm trying to add that it might have moved a bit faster than the fundamental changes the 2 agreements + their choice of own development can support. That's my assessment/perception - and one doesn't have to agree with it in any way. But I added to my position myself (as I have done many times in the last 11 years) at a price of 2,00 on 24/4'2024 - i.e., just under 18 months ago - a 7-8 doubling in that period, which I simply don't believe can be justified by what has happened in that period. I understand that the 2,00 was probably too pessimistic, but in the same way, I think a price of 15-16 (2 billion SEK in market value) is probably on the high side now. I didn't consider selling at 11-12, but when I saw that in a very short time I could reduce my exposure with a gain of 40% in + (at the same time as I think 15-16 is too high), I went for it. Now we'll see - when Tesofensine is clarified, I think all of us small investors will reposition ourselves, and then we'll see if I should go in with a bit more at 8 or 22.
  • 13.11.
    ·
    13.11.
    ·
    The headline is .Saniona: Potential in pipeline I guess some stop/loss orders were just triggered. There must be some who got some shares at a discount given the share price last week.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
0
Myynti
Määrä
0

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----
Ylin
-
VWAP
16,28
Alin
-
Vaihto ()
-
VWAP
16,28
Ylin
-
Alin
-
Vaihto ()
-

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q3-osavuosiraportti
27.11.
Menneet tapahtumat
2025 Q2-osavuosiraportti28.8.
2025 Q1-osavuosiraportti28.5.
2024 Yhtiökokous28.5.
2024 Q4-osavuosiraportti27.2.
2024 Q3-osavuosiraportti28.11.2024
Datan lähde: Millistream, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

Q2-osavuosiraportti

Vain PDF

83 päivää sitten

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q3-osavuosiraportti
27.11.
Menneet tapahtumat
2025 Q2-osavuosiraportti28.8.
2025 Q1-osavuosiraportti28.5.
2024 Yhtiökokous28.5.
2024 Q4-osavuosiraportti27.2.
2024 Q3-osavuosiraportti28.11.2024
Datan lähde: Millistream, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

0,0823 SEK/osake
Viimeisin osinko

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Must say that Saniona is showing strength 💪 in a market that is otherwise just taking a breather. Impressive - I am otherwise one of the few who is a bit "critical" of the current price level 👍
    22 t sitten · Muokattu
    ·
    22 t sitten · Muokattu
    ·
    I "chatted" and it added history, depth, and overview to my analysis. And I read lots of reports, analyses, and irrelevant posts in various discussion forums (where I also gladly contribute with empty irrelevant posts, so we can all have something to pass the time with)
  • 15.11.
    ·
    15.11.
    ·
    Ha, ha, super nice. Just discovered that you can mute a person's posts, so they disappear……..AWESOME. Can you guess who I muted?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Slowfox, maybe!
  • 14.11.
    ·
    14.11.
    ·
    Buy and sell on Nordnet is pure rubbish, if one sees it as 3.89 % up
  • 13.11. · Muokattu
    ·
    13.11. · Muokattu
    ·
    Yet another well-founded and fully explained price movement following Affärsvärlden's entirely well-founded warning that things have probably moved a bit fast, and the valuation looks a tad strained. We can hope Saniona becomes the exception :-) : "Affärsvärlden emphasizes that the main scenario for speculative companies is that over time it ends with a large loss for investors." After having realized 2/3 with a decent profit, I now hold 10,000 at AAC 5.84 in Nordnet accounts and 10,000 at AAC 11.15 in bank accounts. I'm calmly waiting for anything between 5 and 25 depending on the panic from a rejection, a sell-off, or FOMO upon approval of Tesofensine in Mexico. Regardless of whether it's 5 or 25, I'll probably buy a bit more when there's clarification and people (perhaps) start to relax a bit. I must repeat that the only ones "messing" with the price here are the small investors who panic or go on a buying spree. Well, it's certainly entertaining to read along.
    14.11.
    ·
    14.11.
    ·
    It's simply not a sustainable argument to say "it has risen a lot, so it should fall". And the risk/probability is precisely included in a thorough analysis such as the one Redeye has made, with a base of 19 SEK. One should not then again include the risk of something going wrong - then it's a double safety factor.. But I agree that it is fully understandable that the stock price reacts to such an article. When one considers the total number of owners of the stock, and how few may have familiarized themselves 100% with the company, then there must be many who rely on the analyses and press releases that are announced.
    14.11. · Muokattu
    ·
    14.11. · Muokattu
    ·
    I agree with that - and I certainly hope it's not the only thing you read from my post. And I would say I might have looked into the case a bit more than the average :-). In any case, I'm trying to add that it might have moved a bit faster than the fundamental changes the 2 agreements + their choice of own development can support. That's my assessment/perception - and one doesn't have to agree with it in any way. But I added to my position myself (as I have done many times in the last 11 years) at a price of 2,00 on 24/4'2024 - i.e., just under 18 months ago - a 7-8 doubling in that period, which I simply don't believe can be justified by what has happened in that period. I understand that the 2,00 was probably too pessimistic, but in the same way, I think a price of 15-16 (2 billion SEK in market value) is probably on the high side now. I didn't consider selling at 11-12, but when I saw that in a very short time I could reduce my exposure with a gain of 40% in + (at the same time as I think 15-16 is too high), I went for it. Now we'll see - when Tesofensine is clarified, I think all of us small investors will reposition ourselves, and then we'll see if I should go in with a bit more at 8 or 22.
  • 13.11.
    ·
    13.11.
    ·
    The headline is .Saniona: Potential in pipeline I guess some stop/loss orders were just triggered. There must be some who got some shares at a discount given the share price last week.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
0
Myynti
Määrä
0

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----
Ylin
-
VWAP
16,28
Alin
-
Vaihto ()
-
VWAP
16,28
Ylin
-
Alin
-
Vaihto ()
-

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt